✦ LIBER ✦

Challenges and opportunities for discovery of disease biomarkers using urine proteomics

✍ Scribed by Alex Kentsis

Book ID: 108973112
Publisher: John Wiley and Sons
Year: 2011
Tongue: English
Weight: 124 KB
Volume: 53
Category: Article
ISSN: 1328-8067
DOI: 10.1111/j.1442-200x.2010.03253.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Proteomic discovery of CSF biomarkers fo

Proteomic discovery of CSF biomarkers for Alzheimer's disease

✍ Jing Zhang; Thomas J. Montine 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 39 KB 👁 2 views

Proteomic identification of biomarkers r

Proteomic identification of biomarkers related to Helicobacter pylori-associated gastroduodenal disease: Challenges and opportunities

✍ Ming-Shiang Wu; Lu-Ping Chow; Jaw-Town Lin; Shyh-Horng Chiou 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB

Biomarker discovery in lung cancer—promi

Biomarker discovery in lung cancer—promises and challenges of clinical proteomics

✍ Ajit Bharti; Patrick C. Ma; Ravi Salgia 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 263 KB

## Abstract Lung cancer is a devastating illness with an overall poor prognosis. To effectively address this disease, early detection and novel therapeutics are required. Early detection of lung cancer is challenging, in part because of the lack of adequate tumor biomarkers. The goal of this review

Discovery of serum biomarkers for pancre

Discovery of serum biomarkers for pancreatic adenocarcinoma using proteomic analysis

✍ Xue, A; Scarlett, C J; Chung, L; Butturini, G; Scarpa, A; Gandy, R; Wilson, S R; 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 773 KB

Proteomics of human cerebrospinal fluid:

Proteomics of human cerebrospinal fluid: Discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics

✍ A.C. Kroksveen; J.A. Opsahl; T.T. Aye; R.J. Ulvik; F.S. Berven 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 737 KB

There is an urgent need for novel biomarkers that can be used to improve the diagnosis, predict the disease progression, improve our understanding of the pathology or serve as therapeutic targets for neurodegenerative diseases. Cerebrospinal fluid (CSF) is in direct contact with the CNS and reflects

Serum proteomics and biomarker discovery

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

✍ Lauren N. Bell; Janice L. Theodorakis; Raj Vuppalanchi; Romil Saxena; Kerry G. B 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 361 KB 👁 2 views

Nonalcoholic fatty liver disease (NAFLD), ranging from relatively benign simple steatosis to progressive nonalcoholic steatohepatitis (NASH) and fibrosis, is an increasingly common chronic liver disease. Liver biopsy is currently the only reliable tool for staging the subtypes of NAFLD; therefore, n